These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6527717)

  • 1. [Protein inhibitors of crystallization. Their characterization and potential role in calcium lithiasis].
    Montalto G; Multigner L; Sarles H; De Caro A
    Nephrologie; 1984; 5(4):155-7. PubMed ID: 6527717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glycoprotein inhibitors of urinary calculi formation].
    Berland Y; Dussol B
    Nephrologie; 1993; 14(4):183-7. PubMed ID: 8232713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium oxalate crystal growth. A new constant composition method for modelling urinary stone formation.
    Sheehan ME; Nancollas GH
    Invest Urol; 1980 May; 17(6):446-50. PubMed ID: 7372431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uropontin in urinary calcium stone formation.
    Hoyer JR
    Miner Electrolyte Metab; 1994; 20(6):385-92. PubMed ID: 7783701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium oxalate crystallization kinetics studied by oxalate-induced turbidity in fresh human urine and artificial urine.
    Kavanagh JP; Jones L; Rao PN
    Clin Sci (Lond); 2000 Feb; 98(2):151-8. PubMed ID: 10657269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of stone formation.
    Worcester EM
    Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of oral administration of Takusya on calcium oxalate crystallization in human whole urine].
    Honda M; Yoshimura K; Miyake O; Yoshioka T; Okuyama A; Yamaguchi S; Utsunomiya M; Koide T; Sugiyama K
    Hinyokika Kiyo; 1997 May; 43(5):333-7. PubMed ID: 9208316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors.
    Meyer JL; Smith LH
    Invest Urol; 1975 Jul; 13(1):36-9. PubMed ID: 166960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment.
    Grases F; Costa-Bauzá A
    Anticancer Res; 1999; 19(5A):3717-22. PubMed ID: 10625946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization.
    Atmani F; Mizon J; Khan SR
    Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of crystal growth of calcium oxalate in gel and its modification by urinary constituents in a new flow model of crystallization.
    Achilles W; Freitag R; Kiss B; Riedmiller H
    J Urol; 1995 Oct; 154(4):1552-6. PubMed ID: 7658589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibody analysis of human pancreatic juice components related to the pancreatic calculi protein].
    Montalto G; Lusher M; De Caro A; Multigner L; Sarles H; Delaage M
    C R Acad Sci III; 1985; 300(6):199-202. PubMed ID: 3919892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein inhibitors of calcium salt crystal growth in saliva, bile and pancreatic juice.
    Verdier JM; Dussol B; Berland Y; Dagorn JC
    Scanning Microsc; 1993 Sep; 7(3):1017-30. PubMed ID: 8146603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [*calcium-oxalate lithogenesis: crystallization in the presence of urine from healthy subjects].
    Beaufays JP; Bouche R; Boistelle R
    Nephrologie; 1995; 16(4):325-31. PubMed ID: 7630471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Uric acid and oxalate lithiasis. Physico-chemical and crystallo-chemical explanation of the relationship].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):211-21. PubMed ID: 7434985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.